Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    "Ocular melanoma"
Show Display Options
Rank Status Study
1 Unknown  Study of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Gemcitabine;   Drug: Treosulfan
2 Active, not recruiting STA-9090(Ganetespib) in Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Intervention: Drug: STA-9090
3 Recruiting Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Sorafenib;   Device: Radioembolization with SIR-Spheres® (Yttrium Microspheres)
4 Withdrawn Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
Condition: Ocular Melanoma
Interventions: Drug: Pegylated Interfon Alpha 2B;   Drug: Placebo
5 Recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma
Conditions: Metastatic Ocular Melanoma;   Metastatic Uveal Melanoma
Interventions: Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Young TIL
6 Completed THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease
Condition: Ocular Melanoma
Intervention: Drug: Ipilimumab
7 Not yet recruiting Definity for Ultrasound of Intraocular Tumors
Condition: Ocular Melanoma
Intervention: Device: Microbubble contrast agent
8 Recruiting Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
9 Recruiting The Role of Inflammation in Ocular Tumours
Condition: Ocular Melanoma
Intervention: Other: cSLO imaging
10 Recruiting Cytogenetic Study of Ocular Melanoma
Condition: Choroidal Melanoma
Intervention:
11 Completed Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Conditions: Ocular Melanoma;   Choroidal Melanoma;   Uveal Melanoma
Intervention:
12 Completed
Has Results
Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Revlimid
13 Completed A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma
Condition: Melanoma
Intervention: Procedure: Laparotomy
14 Terminated Imatinib in Adult Patients With Metastatic Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Imatinib
15 Unknown  Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Condition: Intraocular Melanoma
Interventions: Drug: cisplatin;   Drug: sunitinib malate;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy
16 Completed Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
Conditions: Stage IV Melanoma;   Recurrent Melanoma
Intervention: Biological: recombinant interferon beta
17 Recruiting Percutaneous Hepatic Perfusion vs Best Alternative Care in Patients With Hepatic-dominant Ocular Melanoma
Condition: Melanoma, Ocular
Interventions: Procedure: Melphalan;   Procedure: TACE;   Drug: Dacarbazine;   Drug: Ipilimumab;   Drug: Pembrolizumab
18 Recruiting Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Ocular Melanoma With Extraocular Extension;   Recurrent Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Vorinostat
19 Completed Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: pyrazoloacridine
20 Completed Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Extraocular Extension Melanoma;   Recurrent Intraocular Melanoma
Interventions: Drug: gp100 antigen;   Drug: interleukin-2;   Drug: MART-1 antigen;   Drug: Montanide ISA-51

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.